(Q33846423)

29 July 2017

1 reference

title

Tumor necrosis factor: a master-regulator of leukocyte movement (English)

1 reference

29 July 2017

Sedgwick JD

1

1 reference

29 July 2017

Riminton DS

series ordinal

2

1 reference

29 July 2017

Cyster JG

series ordinal

3

1 reference

29 July 2017

Körner H

series ordinal

4

1 reference

29 July 2017

publication date

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

21

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

110-113

1 reference

Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

Role of cytokines in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

Regulation of autoimmunity by proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

The tumor necrosis factor ligand and receptor families.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

Unlinking tumor necrosis factor biology from the major histocompatibility complex: lessons from human genetics and animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

Development and maturation of secondary lymphoid tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

Cytokines and antibodies in myelin oligodendrocyte glycoprotein-induced experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

TNF-alpha- and IFN-gamma-mediated signal transduction pathways: effects on glial cell gene expression and function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

Crucial role of tumor necrosis factor receptor 1 expression on nonhematopoietic cells for B cell localization within the splenic white pulp

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

Soluble tumor necrosis factor receptor (p75) fusion protein (ENBREL) as a therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901573-X

7 January 2021

10.1016/S0167-5699(99)01573-X

Identifiers

DOI

1 reference

29 July 2017

1 reference